Tim Philipp Baltin
Direktor/Vorstandsmitglied bei STADA ARZNEIMITTEL
Profil
Tim Philipp Baltin is a Member-Supervisory Board at STADA Arzneimittel AG since 2021 and a Principal at Cinven Group Ltd.
since 2017.
He completed his undergraduate degree at RWTH Aachen University in 2013, followed by an MBA from Ludwig-Maximilians-Universität München in 2017.
He also holds a graduate degree from the University of Sydney Business School, which he obtained in 2011.
Aktive Positionen von Tim Philipp Baltin
| Unternehmen | Position | Beginn |
|---|---|---|
| STADA ARZNEIMITTEL | Direktor/Vorstandsmitglied | 01.01.2021 |
Cinven Group Ltd.
 Cinven Group Ltd. Investment ManagersFinance Cinven Group Ltd (Cinven Group) is a private equity firm founded in 1977. The firm is headquartered in London, United Kingdom. | Private-Equity-Analyst | 01.01.2017 |
Ausbildung von Tim Philipp Baltin
| University of Sydney Business School | Graduate Degree |
| RWTH Aachen University | Undergraduate Degree |
| Ludwig-Maximilians-Universität München | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Cinven Group Ltd.
Cinven Group Ltd. Investment ManagersFinance Cinven Group Ltd (Cinven Group) is a private equity firm founded in 1977. The firm is headquartered in London, United Kingdom. | Finance |
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
